Bruker BioScience Shareholders Approve Acquisition of Bruker Optics | GenomeWeb
NEW YORK (GenomeWeb News) - Bruker BioSciences shareholders overwhelmingly voted to approve the acquisition of molecular spectroscopy company Bruker Optics at today's annual meeting, the company said.
The $135 million deal, announced in April, would be paid approximately 59 percent in cash and 41 percent in the company's stock.
The board of directors of Bruker Optics and the independent directors on the board of directors for Bruker BioSciences previously approved the acquisition unanimously.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.